ExCell Bio Group
PrivateLast Round
Series B
Extension
May 10, 2023
Est. Valuation
$1.19B
Total Funding Raised
$193.27M
Company Overview
ExCell Bio Group is a biotechnology company that supplies biological reagents, cell culture media, serum products, and assay kits to customers in the biopharmaceutical, cell and gene therapy, and stem cell research sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExCell Bio Group Comparables
Compare ExCell Bio Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jianshun Biosciences Co., Ltd. | 89% | |
| Shanghai BasalMedia Technologies Co., Ltd. | 89% | |
| Duoning Biotechnology | 88% | |
ExCell Bio Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 10, 2023 | ||||
| Series B Extension | Jan 8, 2023 | ||||
| Growth Equity | Dec 9, 2021 | ||||
| Series B | Oct 26, 2021 | ||||
| Series B Extension | Aug 26, 2021 | ||||
Series B | Jun 17, 2021 |
ExCell Bio Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agricultural Bank of China International | Series B Extension |
| HM Capital | Series B Extension |
| Legend Capital | Series B |
| Yonghua Capital | Series A, Series A Extension |
| CICC Capital | Series B |
| MPC | Series B |
| 金浦产业投资基金管理有限公司 | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2021
$40M round completed with 3 investors.
- Aug 26, 2021
$46.2M round led by CPE
ExCell Bio Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |